Latest profit margin for Synovics Pharmaceuticals: -26.42% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jul 2009
Trailing 12 months ending Jul 2009
Synovics Pharmaceuticals's profit margin stands at -26.42% as of July 2009. That compares with -38.02% in the prior-year period — up 30.5% year over year. That is below the Healthcare sector average of 17.63%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Synovics Pharmaceuticals reported -26.42% in profit margin versus -38.02% a year earlier — a 30.5% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
Synovics Pharmaceuticals sits lower the Healthcare benchmark (17.63%) with a profit margin of -26.42%. That is roughly 249.9% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of -26.42% for Synovics Pharmaceuticals means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Synovics Pharmaceuticals's profit margin evolved across reporting periods, while the comparison chart places SYVC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.